Rocket Lab falls 7.8% after Neutron maiden flight is postponed to 2027

What happened

Rocket Lab (RKLB) fell 7.8% on October 14, 2026, after the company confirmed the Neutron maiden flight would be postponed from 2026 into 2027. The announcement prompted about a 6% fall in extended trading and broader intraday weakness, according to Reuters and Market Watch.

How big was the move

The stock closed at $59.18, a decline that was 1.9 times a typical daily move for this stock and 6.0 percentage points worse than the Industrials sector median on the day. Trading volume was 1.1 times its 20-day average. The S&P 500 fell 1.1% on the day, and with a beta of 2.75 the stock tends to move more than the market, underlining that Tuesday’s drop was large relative to ordinary market swings. The shares also fell 17.7% over the last five sessions, amplifying the one-day move.

In the past five years the stock had 56 sessions with a decline of at least 7.8%. Twenty trading days later the median result was a decline of 0.6%, and 27 of 56 were higher. Taken together, the data point to a large, mostly company-specific move: the stock moved far more than the market and its sector, and the company news is the likely driver.

The technical picture

The stock is trading below its key averages: 15.1% below its 20-day moving average, 15.6% below its 50-day moving average and 27.3% below its 200-day moving average. The 50-day average is below the 200-day average, a sign of a weak longer-term trend. The Relative Strength Index (14 days) was 33, inside the neutral 30-to-70 range. The shares are 60.8% below the 52-week high and have fallen 6.9% over one month and 12.1% over three months, measures that underline recent downside momentum.

Sixty-day volatility was 65% annualized, which is lower than 78% of its own readings over five years, suggesting current price swings are not at the record extremes seen historically for this stock.

Fundamentals and valuation

Over the four quarters through June 30, 2026, revenue was $769.1 million, up 52.5% from a year earlier and accelerating versus growth of 45.8% one quarter earlier. Diluted earnings per share for that period were $-0.28 and gross margin was 37.3%, up from 29.0% a year earlier. Operating margin was 29.1% versus 44.1% a year earlier. Free-cash-flow margin stood at 48.3%, and return on invested capital was 5.3%. The balance sheet showed net cash of $2.00 billion. Share count over one year increased by 22.2%.

Together these figures depict a company with rapid top-line growth and improving gross profitability, while operating margin narrowed versus the prior year. Valuation metrics show a free-cash-flow yield of 0.9%, and the market placed a $39.48 billion value on the company at the close.

Earnings and analyst expectations

Rocket Lab last reported on August 10, 2026, posting earnings per share of $-0.08 against $-0.06 expected, a 37.2% shortfall to estimates. Typical two-day reactions after recent reports saw the stock fell 1.3%. The firm has recorded zero consecutive quarters beating estimates, though the average surprise over the last four reports was 38.0% above estimates.

Analysts covering the stock numbered 21, with 76% rating the shares Buy and a consensus price target of $107.00, which is 80.8% above the closing price. The next report is scheduled for November 9, 2026.

What to watch

• Maiden flight schedule: Rocket Lab confirmed the Neutron maiden flight has been postponed from 2026 into 2027 (reported October 14, 2026).
• Next earnings report: November 9, 2026.
• Last quarterly report: August 10, 2026, earnings per share of $-0.08 versus $-0.06 expected.
• Market value: $39.48 billion.